Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) has been a traditional first-line antibiotic treatment for acute cystitis; however, guidelines do not recommend TMP-SMX in regions where Escherichia coli resistance exceeds 20%. While resistance is increasing, there are no recent Canadian estimates...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2013/547848 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832555057345724416 |
---|---|
author | Warren J McIsaac Rahim Moineddin Christopher Meaney Tony Mazzulli |
author_facet | Warren J McIsaac Rahim Moineddin Christopher Meaney Tony Mazzulli |
author_sort | Warren J McIsaac |
collection | DOAJ |
description | BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) has been a traditional first-line antibiotic treatment for acute cystitis; however, guidelines do not recommend TMP-SMX in regions where Escherichia coli resistance exceeds 20%. While resistance is increasing, there are no recent Canadian estimates from a primary care setting to guide prescribing decisions. |
format | Article |
id | doaj-art-7cf34722e24a41bc9c710c43142ea156 |
institution | Kabale University |
issn | 1712-9532 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Infectious Diseases and Medical Microbiology |
spelling | doaj-art-7cf34722e24a41bc9c710c43142ea1562025-02-03T05:49:46ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322013-01-0124314314910.1155/2013/547848Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in CanadaWarren J McIsaac0Rahim Moineddin1Christopher Meaney2Tony Mazzulli3Granovsky-Gluskin Family Medicine Centre, Ray D Wolfe Department of Family Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, CanadaDepartment of Community and Family Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Community and Family Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Microbiology, Mount Sinai Hospital and University Health Network, Toronto, Ontario, CanadaBACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) has been a traditional first-line antibiotic treatment for acute cystitis; however, guidelines do not recommend TMP-SMX in regions where Escherichia coli resistance exceeds 20%. While resistance is increasing, there are no recent Canadian estimates from a primary care setting to guide prescribing decisions.http://dx.doi.org/10.1155/2013/547848 |
spellingShingle | Warren J McIsaac Rahim Moineddin Christopher Meaney Tony Mazzulli Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada Canadian Journal of Infectious Diseases and Medical Microbiology |
title | Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada |
title_full | Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada |
title_fullStr | Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada |
title_full_unstemmed | Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada |
title_short | Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada |
title_sort | antibiotic resistant escherichia coli in women with acute cystitis in canada |
url | http://dx.doi.org/10.1155/2013/547848 |
work_keys_str_mv | AT warrenjmcisaac antibioticresistantescherichiacoliinwomenwithacutecystitisincanada AT rahimmoineddin antibioticresistantescherichiacoliinwomenwithacutecystitisincanada AT christophermeaney antibioticresistantescherichiacoliinwomenwithacutecystitisincanada AT tonymazzulli antibioticresistantescherichiacoliinwomenwithacutecystitisincanada |